Evotec SE (ETR:EVT – Get Free Report)’s stock price traded up 0.3% on Tuesday . The company traded as high as €10.50 ($11.17) and last traded at €10.50 ($11.17). 2,505,337 shares traded hands during trading, an increase of 84% from the average session volume of 1,360,000 shares. The stock had previously closed at €10.47 ($11.14).
Evotec Trading Up 0.3 %
The company has a debt-to-equity ratio of 46.81, a quick ratio of 2.97 and a current ratio of 1.83. The company has a market capitalization of $1.86 billion, a price-to-earnings ratio of -10.94, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05. The firm has a fifty day moving average price of €6.61 and a 200-day moving average price of €7.72.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
See Also
- Five stocks we like better than Evotec
- Dividend Capture Strategy: What You Need to Know
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- ETF Screener: Uses and Step-by-Step Guide
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
